Cervical cancer — staging
ESGO/ESTRO/ESP cervical cancer imaging guidance (2023)The decision imaging supports is surgery versus chemoradiotherapy, and it turns on parametrial invasion — an interruption of the low-signal cervical stromal ring. That ring is only visible on thin, small-field-of-view T2 acquired in planes referenced to the cervical canal, not to the patient.
Histologically confirmed cervical carcinoma requiring assessment of tumour size, parametrial and vaginal extension, nodal disease and hydronephrosis before treatment.
Referenced decision support — confirm against your local protocol.
Decision support, not a directive. Protocols and timings shown are typical published ones — your local protocol takes precedence, and the vetting radiologist decides.
- Parametrial invasion is defined by loss of the low-signal fibrous stromal ring that surrounds the cervical canal, and that ring is a millimetre-scale structure. Resolving it needs a small field of view, thin slices, and oblique planes referenced to the canal itself — oblique-axial perpendicular to it for parametrial assessment and oblique-coronal parallel to it for the fornices and vagina. Planes referenced to the patient rather than the canal are the standard cause of parametrial overcall, and an overcall moves a woman from surgery to chemoradiotherapy. A separate large field-of-view acquisition handles nodes and the upper abdomen.
Nothing needs resolving before this goes ahead. Routine checks below are owned downstream.
How was this decided?
- pathwaystandard — Adults — local and nodal staging
- rulerule-mr-device-screening — MR safety screening for implants and foreign bodies; checked by Radiographer at the scanner
- rulerule-contrast-reaction-premed — Prior contrast reaction and elective premedication; checked by Nurse before the scan
- rulerule-gadolinium-renal — Kidney function and gadolinium-based contrast; checked by Radiographer at the scanner
- rulerule-pregnancy-gadolinium — Gadolinium in known or possible pregnancy; checked by Radiographer at the scanner
- rulerule-iv-access — Intravenous access adequate for the planned injection; checked by Radiographer at the scanner
Decision support only. Local protocol takes precedence.
Handled at the scanner(2)nothing for you to do
Settled and owned downstream. Each returns to a radiologist only on the stated trigger.
- MR safety screening for implants and foreign bodiesComplete the MR safety questionnaire, verify implant labelling and its stated conditions of use against this scanner and this protocol, and ensure no ferromagnetic object enters Zone IV.Radiographer at the scannerBefore the scanFlags back if: An implant or retained foreign body that is MR Unsafe, unlabelled, or cannot be identified; or an MR Conditional device whose stated conditions this scanner or the requested protocol cannot satisfy; or a credible unexcluded intraocular metallic foreign body history.
- Intravenous access adequate for the planned injectionSite and test a cannula that supports the protocol flow rate, preferring an antecubital or large forearm vein, and observe the injection for extravasation. A 20-gauge or larger cannula is preferred for flow rates of 3 mL/s or more.Radiographer at the scannerAt the scannerFlags back if: No cannula can be sited that supports the protocol flow rate — for example only a 22-gauge hand or foot cannula for a CT angiogram needing 4–5 mL/s; or the only available access is a central line or port that is not labelled power-injectable; or an extravasation occurs.
Pathways
Big forks are separate pathways; the first whose conditions match is the one used.
Adults — local and nodal staging
Matches your inputsDefault| Role | Study & protocol | Why this answers the question |
|---|---|---|
| First line | MRI Pelvis (Gynaecological) MRI Pelvis — cervical cancer staging usually appropriate | Parametrial invasion is defined by loss of the low-signal fibrous stromal ring that surrounds the cervical canal, and that ring is a millimetre-scale structure. Resolving it needs a small field of view, thin slices, and oblique planes referenced to the canal itself — oblique-axial perpendicular to it for parametrial assessment and oblique-coronal parallel to it for the fornices and vagina. Planes referenced to the patient rather than the canal are the standard cause of parametrial overcall, and an overcall moves a woman from surgery to chemoradiotherapy. A separate large field-of-view acquisition handles nodes and the upper abdomen. |
| Second line | FDG PET-CT FDG PET-CT — skull base to mid-thigh | The nodal and distant staging tool in locally advanced disease. Para-aortic nodal involvement extends the radiotherapy field, and detecting it before planning rather than after is the whole reason the study is done up front. |
| Second line | CT Abdomen and Pelvis CT Abdomen and Pelvis — Portal Venous Phase | Where PET-CT is unavailable, contrast-enhanced CT provides nodal and visceral staging and identifies hydronephrosis, though it cannot assess parametrial invasion and should never be substituted for the pelvic MRI. |
Pitfalls
- Imaging in straight anatomical planes rather than planes referenced to the cervical canal, which is the classic cause of parametrial overcall.
- A field of view too large to resolve the low-signal stromal ring, so its integrity cannot be judged at all.
- Superior coverage stopping at the pelvic brim, missing para-aortic nodes and hydronephrosis.
- Scanning shortly after cone biopsy, when oedema is indistinguishable from residual disease.
- Substituting CT for MRI in local staging. It cannot see the structure the decision depends on.
Priors — what to pull first
- Record the date of any cone biopsy or large loop excision. Post-procedural oedema mimics residual tumour and imaging too soon after it overstages.
- For response assessment after chemoradiotherapy, the pre-treatment study planned in the same oblique geometry is the only useful comparator.
What makes a good request
- Current European guidance places MRI as the standard for local staging and pelvic nodal assessment, with PET-CT adding para-aortic nodal and distant assessment in locally advanced disease.
- Coverage must extend superiorly to the renal hila. Hydronephrosis alters stage in its own right, and the para-aortic nodal station changes the radiotherapy field.
- For fertility-sparing trachelectomy the decisive measurement is the distance from the upper tumour margin to the internal os, and it requires a sagittal acquisition planned along the canal.
- Contrast is not universally required — high-resolution T2 with diffusion answers most local staging questions — and is added mainly for suspected bladder or rectal invasion, fistula, small-volume disease and post-treatment assessment. Practice differs on whether it is routine.
How these studies are acquired
Contrast, phases and timing for every study on the pathways above.
Confirm locally
- MRI Pelvis — cervical cancer staging: timings are typical — confirm against local protocol.
- Timings, contrast volumes and rates above are typical published values. Your department's protocol, scanner and patient population decide the actual numbers.
- Safety thresholds and premedication policy follow local policy where it differs from the cited guidance.
References
- The role of imaging in cervical cancer staging: ESGO/ESTRO/ESP guidelines (2023 update) · Other
- ESUR female pelvic MRI guidance · ESUR
- American College of Radiology Manual on MR Safety: 2024 Update and Revisions. Radiology. · ACR MR Safety
- ACR Manual on MR Safety — zoning, MR Safe / MR Conditional / MR Unsafe labelling, and screening of patients and personnel · ACR MR Safety
- Safety of MRI in patients with cardiac implantable electronic devices — conditions of use, device interrogation and monitoring · Primary literature
- ACR Manual on Contrast Media — premedication regimens (elective oral prednisone 50 mg at 13/7/1 h plus diphenhydramine 50 mg at 1 h; methylprednisolone 32 mg at 12 and 2 h; accelerated IV hydrocortisone 200 mg or methylprednisolone 40 mg every 4 h; regimens under 4–5 h lack evidence of efficacy) · ACR Contrast Manual
- Management and Prevention of Hypersensitivity Reactions to Radiocontrast Media: A Consensus Statement from the ACR and the AAAAI. J Allergy Clin Immunol Pract, 2025. · Primary literature
- Schabelman E, Witting M. The relationship of radiocontrast, iodine and seafood allergies: a medical myth exposed. J Emerg Med. · Primary literature
- CAR/CSACI Practice Guidance for Contrast Media Hypersensitivity (2025) · Other
- Weinreb JC, Rodby RA, Yee J, Wang CL, Fine D, McDonald RJ, Perazella MA, Dillman JR, Davenport MS. Use of Intravenous Gadolinium-based Contrast Media in Patients with Kidney Disease: Consensus Statements from the ACR and the National Kidney Foundation. — Group II NSF risk: 0 events in 4931 administrations at eGFR <30; upper 95% CI bounds 0.07% overall, 0.2% CKD 5D, 0.5% CKD 5 non-dialysis · ACR/NKF consensus
- Woolen SA et al. Risk of NSF in patients with stage 4 or 5 CKD receiving a group II GBCA: systematic review and meta-analysis. JAMA Intern Med. · Primary literature
- ESUR Contrast Media Guidelines v10.0 — gadolinium agents and NSF risk classification — European practice diverges: after the EMA Article 31 referral the marketing authorisations of several intravenous linear agents (gadodiamide, gadopentetate, gadoversetamide) were suspended, so the ACR "group I" discussion is largely moot in the EU/UK while remaining live in the US · ESUR
- EMA — gadolinium-containing contrast agents Article 31 referral: PRAC confirms restrictions on linear agents · Other
- Contrast Media in Pregnant and Lactating Patients — AJR Special Series on Contrast Media · Primary literature
- ACOG Committee Opinion — Guidelines for Diagnostic Imaging During Pregnancy and Lactation · Other
- ACR-SPR Practice Parameter for the Use of Intravascular Contrast Media · Other
- Behrendt FF et al. Peripheral intravenous power injection of iodinated contrast media through 22G and 20G cannulas: can high flow rates be achieved safely? A clinical feasibility study. · Primary literature
- Pressure injectors for radiologists: a review — extravasation incidence and catheter/flow-rate relationships · Primary literature
Implemented from the cited published sources. Educational and workflow support only; confirm against current guidelines and local policy before clinical use.